BCAB
Price
$0.44
Change
-$0.02 (-4.35%)
Updated
Sep 2, 04:10 PM (EDT)
Capitalization
26.75M
64 days until earnings call
CTMX
Price
$2.06
Change
+$0.02 (+0.98%)
Updated
Sep 2, 04:19 PM (EDT)
Capitalization
336.42M
65 days until earnings call
Interact to see
Advertisement

BCAB vs CTMX

Header iconBCAB vs CTMX Comparison
Open Charts BCAB vs CTMXBanner chart's image
BioAtla
Price$0.44
Change-$0.02 (-4.35%)
Volume$650
Capitalization26.75M
CytomX Therapeutics
Price$2.06
Change+$0.02 (+0.98%)
Volume$538
Capitalization336.42M
BCAB vs CTMX Comparison Chart in %
Loading...
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCAB vs. CTMX commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a Buy and CTMX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (BCAB: $0.46 vs. CTMX: $2.04)
Brand notoriety: BCAB and CTMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 103% vs. CTMX: 48%
Market capitalization -- BCAB: $26.75M vs. CTMX: $336.42M
BCAB [@Biotechnology] is valued at $26.75M. CTMX’s [@Biotechnology] market capitalization is $336.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileCTMX’s FA Score has 1 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • CTMX’s FA Score: 1 green, 4 red.
According to our system of comparison, CTMX is a better buy in the long-term than BCAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 6 TA indicator(s) are bullish while CTMX’s TA Score has 6 bullish TA indicator(s).

  • BCAB’s TA Score: 6 bullish, 4 bearish.
  • CTMX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both BCAB and CTMX are a good buy in the short-term.

Price Growth

BCAB (@Biotechnology) experienced а +27.88% price change this week, while CTMX (@Biotechnology) price change was -3.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

BCAB is expected to report earnings on Nov 05, 2025.

CTMX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($336M) has a higher market cap than BCAB($26.7M). CTMX YTD gains are higher at: 98.058 vs. BCAB (-22.953). CTMX has higher annual earnings (EBITDA): 44.7M vs. BCAB (-63.02M). CTMX has more cash in the bank: 158M vs. BCAB (18.2M). BCAB has less debt than CTMX: BCAB (6.05M) vs CTMX (6.89M). CTMX has higher revenues than BCAB: CTMX (141M) vs BCAB (11M).
BCABCTMXBCAB / CTMX
Capitalization26.7M336M8%
EBITDA-63.02M44.7M-141%
Gain YTD-22.95398.058-23%
P/E RatioN/A4.08-
Revenue11M141M8%
Total Cash18.2M158M12%
Total Debt6.05M6.89M88%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
13
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCABCTMX
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
79%
Momentum
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
80%
MACD
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
74%
Aroon
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADSK314.7026.21
+9.09%
Autodesk
TKNO4.320.01
+0.23%
Alpha Teknova
LUNR8.77-0.13
-1.46%
Intuitive Machines
DJT17.53-0.42
-2.37%
Trump Media & Technology Group Corp
HTCR1.12-0.13
-10.40%
Heartcore Enterprises

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with KYMR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+8.45%
KYMR - BCAB
38%
Loosely correlated
-1.32%
CTMX - BCAB
37%
Loosely correlated
-0.49%
DNLI - BCAB
36%
Loosely correlated
-2.43%
NVO - BCAB
35%
Loosely correlated
+0.62%
GALT - BCAB
34%
Loosely correlated
+0.71%
More

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with BCAB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
-0.49%
BCAB - CTMX
37%
Loosely correlated
+8.45%
THRD - CTMX
37%
Loosely correlated
N/A
RAPT - CTMX
34%
Loosely correlated
-0.70%
KZR - CTMX
34%
Loosely correlated
-0.50%
FATE - CTMX
33%
Loosely correlated
-3.70%
More